NAOMI BLACKBURN: Open Payments
NPI 1144467002 · WEST PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 103 payments from 11 companies in 2025. Trend: 2023 $2,377 · 2024 $2,404 · 2025 $1,606
Food & beverage: $1,606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $524 |
| Teva Pharmaceuticals USA, Inc. | 46 | $459 |
| Gilead Sciences, Inc. | 9 | $183 |
| Alkermes, Inc. | 4 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Braeburn Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| TG Therapeutics, Inc. | 1 | $43 |
| Indivior Inc. | 1 | $23 |
Products named: AUSTEDO XR, MAVYRET, VRAYLAR, Epclusa, CAPLYTA, BRIXADI, VIVITROL, REXULTI.
Industry payments across OH — which companies pay providers there.
